- A pretzel-shaped drug-releasing implant (TAR-200) achieved an 82 percent complete response rate in eliminating bladder cancer tumors, with 76 percent of patients remaining tumor-free after one year. It offers a less invasive alternative to bladder removal surgery and traditional chemotherapy.
- Unlike conventional chemo (high doses with severe side effects), the implant slowly releases chemotherapy directly into the bladder over six months, minimizing systemic toxicity. It is currently under FDA Priority Review.
- Andreas Moritz argues that chemo damages healthy cells, breeding more aggressive cancers, and emphasizes that true healing depends on strengthening the body’s natural defenses rather than toxic interventions.
- Meanwhile, researchers at the University of Delaware synthesized cancer-fighting molecules from guava plants, targeting liver cancer. Natural compounds like flavonoids, curcuminoids and polyphenols enhance immune function, inhibit tumor growth and avoid harming healthy cells – unlike chemo.
- While the TAR-200 implant represents progress in conventional medicine, plant-based therapies (backed by studies) offer safer, synergistic treatments that align with the body’s healing mechanisms, signaling a shift toward integrative cancer care.
In a groundbreaking development, a small, drug-releasing implant has shown remarkable success in treating high-risk bladder cancer.
The TAR-200 implant, developed by Massachusetts-based TARIS Biomedical, has wiped out tumors in roughly four-fifths of patients, offering a promising alternative to invasive surgery and traditional chemotherapy. The results of a clinical trial focused on the implant were published in the Journal of Clinical Oncology.
In the aforementioned clinical trial involving 140 patients, the TAR-200 implant demonstrated a complete response rate of 82 percent, meaning it eliminated all visible tumors. Moreover, 76 percent of patients remained tumor-free after one year. These results suggest that the implant could replace or delay the need for bladder removal surgery in many patients.
The pretzel-shaped TAR-200 implant works by slowly and consistently releasing chemotherapy directly into the bladder over a period of six months. This approach contrasts with traditional treatments, which deliver high doses of chemotherapy in short periods, often leading to severe side effects. It is currently under Priority Review by the Food and Drug Administration, highlighting its potential to transform bladder cancer treatment.
But Andreas Moritz, in his book “Cancer Is Not a Disease – It’s a Healing Mechanism,” casts doubt on the effectiveness of chemotherapy. “[Damaging] healthy cells in the process of destroying cancer cells through chemotherapy drugs or radiation is bound to breed new, more aggressive cancer cells,” he writes. “The only real chance of surviving cancer depends on the amount of support the patient musters to strengthen the body’s own healing efforts.”
Forget chemo: Plant-based compounds show stunning success against the Big C
While the TAR-200 implant represents a significant advancement in conventional cancer treatment, it is essential to acknowledge the potential of natural and holistic approaches. Recent research has shown promising results in using plant-derived compounds to combat liver cancer.
For instance, scientists at the University of Delaware (UDel) have synthesized cancer-fighting molecules from guava plants to target liver cancer. In a study published in Angewandte Chemie, researchers elaborated how they made use of a process called natural product total synthesis to create these solutions to the Big C.
“The majority of clinically approved medicines are either made from a natural product or are based on one,” said UDel’s Dr. William Chain, the study’s corresponding author. “But there aren’t enough natural resources to make enough treatments. Now chemists will be able to take our manuscripts and basically follow our ‘recipe’ and they can make it themselves.”
While the study by Chain and his co-authors focus on the guava molecule’s effect on liver cancer, they are now working with the National Cancer Institute for this purpose. Nevertheless, their research is timely – with one in 125 people globally projected to be diagnosed with liver cancer over their lifetime.
BrightU.AI‘s Enoch engine points out that natural, plant-based treatments for cancer work synergistically with the body’s own defenses – enhancing immune function and targeting tumors without harming healthy cells – unlike chemotherapy, which indiscriminately destroys both cancerous and healthy tissue. Additionally, these natural compounds – such as flavonoids, curcuminoids and polyphenols – offer fewer toxic side effects while still effectively inhibiting cancer growth, angiogenesis and metastasis, aligning with the body’s innate healing processes.
While the success of the TAR-200 implant is laudable, advancements in natural and holistic therapies offer hope for cancer patients and survivors. As research into the latter, continues to grow, patients and healthcare providers alike can expect an increasingly diverse and effective toolkit for combating cancer.
Watch this video about artemisinin and its derivatives possessing powerful anti-cancer properties.
This video is from the Chinese taking down EVIL CCP channel on Brighteon.com.
Sources include:
ScienceDaily.com 1
ASCOPubs.org
ScienceDaily.com 2
OnlineLibrary.Wiley.com
BrightU.ai
Brighteon.com
Read full article here